The DOI matches its Crossref record; 38 of the 41 references it cites were found in a registry or an index; 56 of the 137 sources its claims cite were checked for support.
Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms
Open accessAbstract
Endometriosis, traditionally viewed as a gynecological disorder, is increasingly recognized as a systemic disease with significant cardiovascular implications. Recent studies suggest that women with endometriosis are at higher risk for developing atherosclerosis and other cardiovascular diseases (CVDs), due to chronic systemic inflammation, endothelial dysfunction, oxidative stress, and metabolic disturbances. This review aimed to summarize current evidence on the vascular implications of endometriosis. A literature search was conducted in PubMed and Google Scholar, focusing on studies exploring the relationship between endometriosis and cardiovascular risk. In rare cases, endometriosis can affect extrapelvic locations such as the diaphragm or pericardium, presenting with cyclical chest pain or dyspnea and mimicking cardiopulmonary conditions. These atypical manifestations often delay diagnosis and highlight the need for heightened clinical awareness. Advances in imaging and minimally invasive techniques, including robotic surgery, have improved the detection and management of such presentations. Shared molecular pathways between endometriosis and CVDs, including pro-inflammatory cytokines and metabolic dysregulation, provide a rationale for exploring novel therapeutic approaches. Emerging pharmacologic options such as statins, metformin, or antiplatelet agents may offer dual benefits for both reproductive and cardiovascular health. Given the multifactorial nature of endometriosis, a multidisciplinary approach involving gynecologists, cardiologists, and primary care providers is essential. These findings highlight the need for early cardiovascular risk assessment and tailored preventive strategies in this population.
Overview
CoChat Summary
TL;DR
This narrative review summarizes evidence that endometriosis is associated with increased cardiovascular risk through shared inflammatory, oxidative, endothelial, metabolic, and genetic mechanisms. It also highlights rare supradiaphragmatic/pericardial endometriosis as a diagnostic mimic of cardiopulmonary disease and calls for multidisciplinary cardiovascular risk assessment in affected women.
Key findings
- Women with endometriosis appear to have higher risks of cardiovascular disease: the Nurses’ Health Study II found a 62% higher risk of coronary heart disease, and a UK retrospective analysis reported a 40% higher likelihood of ischemic heart disease and a 26% increased risk of arrhythmia.
- Shared mechanisms include chronic systemic inflammation, oxidative stress, endothelial dysfunction, arterial stiffness, metabolic disturbances such as insulin resistance/dyslipidemia, and overlapping genetic loci including CDKN2B-AS1 on chromosome 9p21 and 7q22.
- Rare supradiaphragmatic endometriosis involving the diaphragm, pleura, or pericardium can cause cyclic chest pain, dyspnea, pneumothorax, or pericardial effusion and is often misdiagnosed as cardiopulmonary disease; case reports describe successful surgical and hormonal management.
- Emerging pharmacologic options such as statins, metformin, antiplatelet agents, and beta-blockers may offer dual reproductive and cardiovascular benefits, but the review states further research is needed.
Methods
- Narrative literature search in PubMed and Google Scholar for studies published between 2010 and 2024, using keywords including “endometriosis,” “cardiovascular disease,” “atherosclerosis,” and related terms.
- Inclusion prioritized original research, systematic reviews, and meta-analyses in peer-reviewed journals; human studies explicitly investigating endometriosis and cardiovascular outcomes; English-language articles with sufficient methodological detail.
- Exclusion criteria included in vitro or animal studies without clinical translation, non-peer-reviewed materials, and studies unrelated to cardiovascular outcomes or the reviewed pathophysiological mechanisms. No new data were generated and no ethical approval was required; generative AI tools assisted in identifying articles and refining search strategies.
Limitations
- The paper states that evidence supporting a systemic inflammatory effect sufficient to drive atherogenesis is currently limited, and that endometriosis’s role in directly accelerating atherosclerotic plaque formation requires further elucidation.
- The paper identifies a research gap in diagnostic tools that assess cardiovascular risk specifically in women with endometriosis, and states that optimal treatment strategies for coexisting endometriosis and cardiovascular conditions are not well established, including long-term safety/efficacy of statins and metformin.
- Evident from the text: this is a narrative review without a registered systematic protocol or meta-analytic synthesis, the search is limited to PubMed and Google Scholar, English-language publications from 2010–2024, and AI tools were used in article identification; causality cannot be established from the largely observational and case-report evidence discussed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
41 Valid · 6 Not valid · 29 Not checked · 18 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is important to note that endometrial deposits near the heart are exceptionally rare, underscoring the need for a high index of suspicion and careful diagnostic evaluation”
§ Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms > 3. Mechanisms Linking Endometriosis and Cardiovascular Disease > 3.5. Supradiaphragmatic Endometriosis: Clinical Cases and Diagnostic Challenges
What the sources say
- Not matchedcites [32] (2025, March 28). Early Detection Breakthrough in Endometriosis: Oxford University Unveils Promising Imaging Study. Available online: https://www.wrh.ox.ac.uk/news/early-detection-breakthrough-in-endometriosis-oxford-university-unveils-promising-imaging-study.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [39] Endometriosis (2025, March 28). Yale Medicine. Available online: https://www.yalemedicine.org/conditions/endometriosis.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [40] Kido, 2022, MRI in the Diagnosis of Endometriosis and Related Diseases, Korean J. Radiol. sourceExperimental — accuracy not yet measured
The Extra-Pelvic Endometriosis section says endometriosis outside the pelvis is rare and discusses diagnostic challenges for thoracic lesions. It does not address deposits near the heart or establish that this specific location is exceptionally rare; no page number is available in our copy. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies suggest that women with endometriosis are at higher risk for developing atherosclerosis and other cardiovascular diseases (CVDs), due to chronic systemic inflammation, endothelial dysfunction, oxidative stress, and metabolic disturbances.”
§ Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms > Abstract
What the sources say
- Partly supportedcites [25] Okoth, 2021, Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: A retrospective matched cohort study, BJOG Int. J. Obstet. Gynaecol. sourceExperimental — accuracy not yet measured
The Cardiovascular diseases results (p. 4) report higher composite CVD risk among women with endometriosis, including higher risks of ischaemic heart disease and cerebrovascular disease. The paper does not report atherosclerosis as a measured outcome; its Biological plausibility discussion (p. 9) offers atherogenesis and inflammatory and oxidative mechanisms as possible explanations, not established causes of the observed risk. (LLM, conf=0.88)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Research indicates that women with endometriosis exhibit increased levels of oxidative stress markers, including reactive oxygen species (ROS) and oxidative damage byproducts such as malondialdehyde (MDA).”
§ Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms > 3. Mechanisms Linking Endometriosis and Cardiovascular Disease > 3.1. Associations Between Endometriosis and Cardiovascular Risk Factors
What the sources say
- Partly supportedcites [8] Cacciottola, L., Donnez, J., and Dolmans, M.-M. (2021). Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?. Int. J. Mol. Sci., 22. sourceExperimental — accuracy not yet measured
Section 4.1 reports increased ROS levels in endometriotic lesions and cells from subjects with endometriosis. The cited paper does not report increased malondialdehyde (MDA); searches for “malondialdehyde” and “MDA” found no supporting passage in our copy. (LLM, conf=0.87)
- Partly supportedcites [9] Clower, L., Fleshman, T., Geldenhuys, W.J., and Santanam, N. (2022). Targeting Oxidative Stress Involved in Endometriosis and Its Pain. Biomolecules, 12. sourceExperimental — accuracy not yet measured
Section 2.2 reports elevated oxidative stress markers in endometriosis patients and specifically says MDA was significantly elevated compared with controls. It identifies ROS as an oxidative stress marker but does not establish that ROS levels themselves were elevated; it also notes conflicting findings across markers. No page number is available in our copy. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, immunological disturbances present in endometriosis may exacerbate inflammatory processes within blood vessels, increasing the risk of developing atherosclerosis [6,7].”
§ Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms > 1. Introduction
What the sources say
- Not matchedcites [6] (2025, March 28). Endometrioza i Ryzyko Sercowo-Naczyniowe Idą w Parze?. Polpharma Dla Ciebie., Available online: https://polpharmadlaciebie.pl/wiedza/biuletyn-stetoskop/wydanie-listopad-2024/endometrioza-i-ryzyko-sercowo-naczyniowe-ida-w-parze.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [7] Chopyak, 2022, Immunopathogenesis of endometriosis—A novel look at an old problem, Cent. Eur. J. Immunol. sourceExperimental — accuracy not yet measured
The Immune factors and Endometriosis and autoimmunity sections describe immune disturbances and inflammation in endometriosis. The Etiology and pathogenesis section reports increased cardiovascular comorbidity but says it is unknown whether that is a consequence of endometriosis. Our copy does not connect these disturbances to inflammation within blood vessels or specifically to atherosclerosis. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For instance, studies using non-invasive Endo-PAT measurements have found lower Reactive Hyperemia Index (RHI) values in endometriosis patients, a marker of endothelial dysfunction, compared to controls.”
§ Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms > 3. Mechanisms Linking Endometriosis and Cardiovascular Disease > 3.1. Associations Between Endometriosis and Cardiovascular Risk Factors
What the sources say
- Not matchedcites [11] Gerlach, A. (2025, March 28). Patients with Endometriosis Have an Increased Risk of Developing Cardiovascular Disease. Pharmacy Times. Available online: https://www.pharmacytimes.com/view/patients-with-endometriosis-have-an-increased-risk-of-developing-cardiovascular-disease.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [12] Smyk, J.M., Danielecka, Z., Kotowska, M., Zawadka, M., Andruszkiewicz, P., Grąt, M., Główczyńska, R., Grabowski, M., Gąsecka, A., and Romejko-Wolniewicz, E. (2024). Cardiovascular risks and endothelial dysfunction in reproductive-age women with endometriosis. Sci. Rep., 14. source
The Materials and methods section says endothelial function was measured non-invasively with EndoPAT 2000 and expressed as RHI. The Results section reports lower mean RHI in patients with endometriosis than in healthy controls (1.7 vs. 2.0; p = 0.037) and defines low RHI as endothelial dysfunction. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
41 more claims · 21 with their cited sources checked
Create a free account to see all 94 claims and every source verdict.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 12
Citations
Cites
Libby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0106-z · Cited by 3,211 · cited 3×
“Nonetheless, it is important to note that the inflammatory response in endometriosis is primarily localized to the pelvic cavity, and evidence supporting a systemic inflammatory effect sufficient to drive atherogenesis is currently limited [15,16].”
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425 · cited 3×
“This localized immune dysregulation may influence endothelial function and contribute to subtle vascular remodeling observed in endometriosis [1].”
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961 · cited 2×
“Other symptoms may include bowel or urinary discomfort, heavy menstrual bleeding, intermenstrual spotting, infertility, fatigue, and gastrointestinal disturbances such as bloating, nausea, diarrhea, or constipation [1,4].”
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914 · cited 1×
“This antioxidant action mitigates the oxidative damage often exacerbated in cardiovascular and metabolic diseases, a pathway also relevant in endometriosis, where increased oxidative stress and inflammation drive disease progression [13,14].”
Endometriosis-associated infertility: From pathophysiology to tailored treatment
Bonavina, G., & Taylor, H. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020827 · Cited by 319 · cited 1×
“Furthermore, the cellular dissemination hypothesis proposes that endometrial cells spread via blood or lymphatic pathways, accounting for rare cases of extra-abdominal endometriosis [3,4].”
Endometriosis and Risk of Coronary Heart Disease
Mu, F., Rich-Edwards, J., Rimm, E. B., Spiegelman, D., & Missmer, S. A. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002224 · Cited by 235 · cited 1×
“These alarming statistics underscore the importance of further research into the intricate interplay between endometriosis and cardiovascular health to develop more effective strategies to protect women affected by this condition [20,26,27].”
Targeting Oxidative Stress Involved in Endometriosis and Its Pain
Clower, L., Fleshman, T., Geldenhuys, W. J., & Santanam, N. (2022) · Biomolecules · doi:10.3390/biom12081055 · Cited by 145 · cited 2×
“Nuclear factor kappa B (NF-κ B), a transcription factor activated in response to oxidative stress, plays a central role in amplifying inflammatory signaling pathways rather than serving as a direct oxidative stress marker [8,9].”
Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?
Cacciottola, L., Donnez, J., & Dolmans, M.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137138 · Cited by 118 · cited 2×
“Nuclear factor kappa B (NF-κ B), a transcription factor activated in response to oxidative stress, plays a central role in amplifying inflammatory signaling pathways rather than serving as a direct oxidative stress marker [8,9].”
Okoth, K., Wang, J., Zemedikun, D., Thomas, G., Nirantharakumar, K., & Adderley, N. (2021) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16692 · Cited by 88 · cited 1×
“Furthermore, the study indicated that endometriosis may be associated with a 26% increased risk of arrhythmia [25].”
MRI in the Diagnosis of Endometriosis and Related Diseases
Kido, A., Himoto, Y., Moribata, Y., Kurata, Y., & Nakamoto, Y. (2022) · Korean Journal of Radiology · doi:10.3348/kjr.2021.0405 · Cited by 69 · cited 1×
“It is important to note that endometrial deposits near the heart are exceptionally rare, underscoring the need for a high index of suspicion and careful diagnostic evaluation [32,39,40].”
Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study
Farland, L. V., Degnan, W. J., Bell, M. L., Kasner, S. E., Liberman, A. L., Shah, D. K., Rexrode, K. M., & Missmer, S. A. (2022) · Stroke · doi:10.1161/strokeaha.122.039250 · Cited by 67 · cited 1×
“These alarming statistics underscore the importance of further research into the intricate interplay between endometriosis and cardiovascular health to develop more effective strategies to protect women affected by this condition [20,26,27].”
Irritable bowel syndrome and endometriosis: New insights for old diseases
Viganò, D., Zara, F., & Usai, P. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.12.017 · Cited by 60
Regulatory Actions of Estrogen Receptor Signaling in the Cardiovascular System
Ueda, K., Adachi, Y., Liu, P., Fukuma, N., & Takimoto, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00909 · Cited by 60 · cited 1×
“This antioxidant action mitigates the oxidative damage often exacerbated in cardiovascular and metabolic diseases, a pathway also relevant in endometriosis, where increased oxidative stress and inflammation drive disease progression [13,14].”
Song, Y., Choi, J.-E., Kwon, Y.-J., Chang, H.-J., Kim, J. O., Park, D.-H., Park, J.-M., Kim, S.-J., Lee, J. W., & Hong, K.-W. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02751-3 · Cited by 41 · cited 2×
“The genetic markers are thought to influence shared mechanisms like immune response, cellular adhesion, and angiogenesis, pathways that can exacerbate both cardiovascular conditions and endometriotic tissue proliferation [17,18].”
Immunopathogenesis of endometriosis—A novel look at an old problem
Chopyak, V. V., Koval, H. D., Havrylyuk, A. M., Lishchuk-Yakymovych, K. A., Potomkina, H. A., & Kurpisz, M. K. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.113830 · Cited by 41 · cited 1×
“Moreover, immunological disturbances present in endometriosis may exacerbate inflammatory processes within blood vessels, increasing the risk of developing atherosclerosis [6,7].”
Menstrual Effluent Provides a Novel Diagnostic Window on the Pathogenesis of Endometriosis
Nayyar, A., Saleem, M. I., Yilmaz, M., DeFranco, M., Klein, G., Elmaliki, K., Kowalsky, E., Chatterjee, P. K., Xue, X., Viswanathan, R., et al. (2020) · Frontiers in Reproductive Health · doi:10.3389/frph.2020.00003 · Cited by 40
Arterial stiffness is increased in young women with endometriosis
Tani, A., Yamamoto, S., Maegawa, M., Kunimi, K., Matsui, S., Keyama, K., Kato, T., Uemura, H., Kuwahara, A., Matsuzaki, T., et al. (2015) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2014.992871 · Cited by 37 · cited 4×
“This underscores the need for a comprehensive approach to risk assessment and management in women with endometriosis, focusing on both systemic inflammation and vascular health [15].”
InfluentialThoracic Endometriosis Syndrome: A Comprehensive Review and Multidisciplinary Approach to Management
Nezhat, C., Amirlatifi, N., Najmi, Z., & Tsuei, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247602 · Cited by 36 · cited 1×
“Clinical manifestations may include cyclic chest pain, dyspnea, and even recurrent pneumothorax [28–30].”
Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study
Havers-Borgersen, E., Hartwell, D., Ekelund, C., Butt, J. H., Østergaard, L., Holgersson, C., Schou, M., Køber, L., & Fosbøl, E. L. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae563 · Cited by 35
Rafi, U., Ahmad, S., Bokhari, S. S., Iqbal, M. A., Zia, A., Khan, M. A., & Roohi, N. (2021) · Mediators of Inflammation · doi:10.1155/2021/3425560 · Cited by 30 · cited 1×
“This emerging evidence underscores the need for the heightened awareness of cardiovascular risks in women with endometriosis and encourages further investigation into targeted prevention and intervention strategies for this population [19,20].”
Could statins constitute a novel treatment for endometriosis? Systematic review of the literature
Gibran, L., Maranhão, R. C., Abrão, M. S., Baracat, E. C., & Podgaec, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.05.028 · Cited by 29 · cited 1×
“Statins, commonly used to manage cholesterol, possess anti-inflammatory properties that could reduce the severity of endometriosis-related pain and lesion progression by inhibiting inflammatory mediators like cytokines and prostaglandins [46].”
Aherrahrou, R., Reinberger, T., Hashmi, S., & Erdmann, J. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae161 · Cited by 25 · cited 2×
“The genetic markers are thought to influence shared mechanisms like immune response, cellular adhesion, and angiogenesis, pathways that can exacerbate both cardiovascular conditions and endometriotic tissue proliferation [17,18].”
Ceccaroni, M., Roviglione, G., Rosenberg, P., Pesci, A., Clarizia, R., Bruni, F., Zardini, C., Ruffo, G., Placci, A., Crippa, S., et al. (2012) · Videosurgery and Other Miniinvasive Techniques · doi:10.5114/wiitm.2011.26758 · Cited by 24 · cited 1×
“This case highlights the importance of considering a patient’s reproductive future and individualizing care plans in managing complex forms of extrapelvic endometriosis [36].”
Laparoscopic excision of pericardial and diaphragmatic endometriosis
Nguyen, D. B., Gilbert, S., Arendas, K., Jago, C. A., & Singh, S. S. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.09.152 · Cited by 22
Cardiovascular risks and endothelial dysfunction in reproductive-age women with endometriosis
Smyk, J. M., Danielecka, Z., Kotowska, M., Zawadka, M., Andruszkiewicz, P., Grąt, M., Główczyńska, R., Grabowski, M., Gąsecka, A., & Romejko-Wolniewicz, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-73841-7 · Cited by 22 · cited 1×
“This dysfunction, along with greater arterial stiffness measured by the Augmentation Index (AI), signals a higher cardiovascular risk among these patients [11,12].”
Pericardial, pleural, and diaphragmatic endometriosis
Ceccaroni, M., Clarizia, R., & Placci, A. (2010) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.07.064 · Cited by 19 · cited 2×
“These factors highlight the necessity of adopting a holistic, patient-oriented framework in clinical care [41,42].”
Doroftei, B., Ilie, O.-D., Balmus, I.-M., Ciobica, A., Maftei, R., Scripcariu, I., Simionescu, G., Grab, D., Stoian, I., & Ilea, C. (2021) · Diagnostics · doi:10.3390/diagnostics11081434 · Cited by 19 · cited 1×
“Additionally, the findings suggest that oxidative stress in endometriosis patients may impair normal immune responses, intensifying inflammation that further affects cardiovascular health [10].”
Long, Q., Zheng, H., Liu, X., & Guo, S.-W. (2019) · Reproductive Sciences · doi:10.1177/1933719119828066 · Cited by 16
Thoracic and diaphragmatic endometriosis: An overview of diagnosis and surgical treatment
McKee, D. C., Mansour, T., & Wasson, M. N. (2022) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000792 · Cited by 16
Sapmaz, T., Coskun, G., Saker, D., Pence, H. H., Keles, P., Hayretdag, C., Kuras, S., Topkaraoglu, S., Erdem, E., Efendic, F., et al. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153951 · Cited by 15 · cited 1×
“…for type 2 diabetes, may provide adjunctive benefits in endometriosis treatment by addressing insulin resistance and inflammation, as well as modulating pathways like mTOR and reducing the expression of vascular endothelial growth factor (VEGF), which plays a key role in lesion angiogenesis [47].”
Effects of repeated propranolol administration in a rat model of surgically induced endometriosis
Uzunlar, O., Ozyer, S., Engin-Ustun, Y., Moraloglu, O., Gulerman, H. C., Caydere, M., Keskin, S. M., & Mollamahmutoglu, L. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.09.025 · Cited by 14 · cited 1×
“Beta-blockers, primarily used in cardiovascular conditions, have been investigated for their potential to alleviate pain and inflammation in endometriosis by modulating sympathetic nervous system activity and reducing pro-inflammatory cytokine release [44,45].”
The pleura and the endocrine system
Sorino, C., Negri, S., Spanevello, A., & Feller-Kopman, D. J. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.12.034 · Cited by 11 · cited 1×
“This process involves menstrual debris entering the pelvic cavity and spreading to the pericardium via the bloodstream or lymphatic system [31–35].”
Catamenial pneumothorax recurrence due to endometriosis
Tsakiridis, K., Triantafilopoulou, K., Minadakis, G., Zatagias, A., Sapalidis, K., Kosmidis, C., Ioannidis, A., Romanidis, K., Oikonomou, P., Sevva, C., et al. (2020) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2020.101036 · Cited by 11 · cited 2×
“Medications such as gonadotropin-releasing hormone (GnRH) agonists, progestogens, and combined oral contraceptives are commonly used to suppress endogenous estrogen production, thereby attenuating the proliferation and activity of ectopic endometrial lesions [41].”
Presumption of pericardial endometriosis using MRI: Case report and review of the literature
Charpentier, E., Petit, E., Beranger, S., & Azarine, A. (2019) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2018.06.009 · Cited by 9 · cited 1×
“On echocardiography, this manifests as an anechoic space surrounding the heart [32,33].”
Endometriosis and aspirin: a systematic review
Yang, Y., Lai, H., Li, Z., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409469 · Cited by 7 · cited 1×
“An-tiplatelet drugs, such as aspirin, may help reduce inflammation and limit the progression of endometrial lesions by inhibiting platelet aggregation and thromboxane production, with some evidence suggesting that endometriosis may have a prothrombotic component [43].”
Bachi, A., Bille, A., & Khazali, S. (2023) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2023.03.026 · Cited by 6 · cited 1×
“This case underscores the effectiveness of multidisciplinary collaboration and the role of advanced surgical techniques in managing extensive thoracic endometriosis [37].”
Tripathi, A., Arsha, S., Thapa, A., Thapa, S., Chand, S., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000759 · Cited by 4 · cited 1×
“Insulin resistance exacerbates lipid disorders and contributes to hypertension through sympathetic nervous system activation and sodium retention in the kidneys [21–24].”
Catamenial pneumothorax due to heterotopic endometriosis in the pericardium
Takigawa, Y., Mizuno, D., Iga, N., & Fujimoto, N. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-240335 · Cited by 3 · cited 2×
“This process involves menstrual debris entering the pelvic cavity and spreading to the pericardium via the bloodstream or lymphatic system [31–35].”
Research works printed but not linked: 1
- Sarmast, 2019, Cardiac Involvement Resulting from Thoracic Endometriosis, Cardiovasc. Surg. Interv., 1, 1002
Cited by
Zahiri, Z., Alborzi, S., Hosseini, S. S. M., Sharifian, F., Khonsarian, Z. S., Goldiani, N. K., Danjeh, M., Etezadi, A., & Amirlatifi, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116988 · Cited by 1
Sympathetic neural control of blood pressure across the premenopausal lifespan
Saboune, J., Boyes, N. G., Limberg, J. K., & Usselman, C. W. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00739.2025
Flores, A. P., & Gallego, L. P. (2026) · Actualización en Medicina de Familia · doi:10.55783/amf.220302
Association between preeclampsia and eclampsia in Black women with endometriosis: a scoping review
Alaribe, C. C., & Sapre, K. D. (2026) · BMC Public Health · doi:10.1186/s12889-026-27739-w
“Additionally, given emerging evidence linking endometriosis [66, 67] to an increased risk of long-term cardiovascular disease, future studies should adopt a life-course perspective to understand how early gynecologic conditions contribute to later cardiovascular risk.”
Zahiri, Z., Alborzi, S., Majlesi, Z. A., Farahani, N., Zamanifard, S., Etezadi, A., & Nikdoust, F. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117072 · Cited by 1
Metadata
- Authors
- Szpila, G., Szczotka, J., Suchodolski, A., & Szulik, M.
- Affiliations
- 4. Wojskowy Szpital Kliniczny z Polikliniką (PL)
- Medical University of Silesia (PL)
- Corresponding author
- Szulik, Mariola
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2025-06-08
- Volume
- 15
- Issue
- 12
- Pages
- 1458
- ISSN
- 2075-4418 (ISSN-L)
- PMC
- PMC12192228
- OpenAlex
- W4411158352
- Cited by
- 7
- References
- 41
- Citations by year
- 2026: 7
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diagnostics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- endometriosis, cardiovascular disease, atherosclerosis, systemic inflammation, endothelial dysfunction, oxidative stress, metabolic dysfunction, diaphragmatic endometriosis, inflammatory cytokines, statins, metformin, antiplatelet agents, cardiovascular risk assessment, multidisciplinary care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
